Kreaxi
  • Home
  • Company
  • Funds
  • Team
  • Portfolio
  • News
  • Contact
  • Français
Select Page
INALVE

INALVE

INALVE Develops an innovative system for growing microalgae for animal...
C4DIAGNOSTICS

C4DIAGNOSTICS

C4DIAGNOSTICS C4DIAGNOSTICS develops fast and reliable microbiology diagnostic...
HYSILABS

HYSILABS

HYSILABS HySiLabs develops an innovative solution to facilitate hydrogen...
DIABELOOP

DIABELOOP

DIABELOOP Diabeloop develops and commercializes a revolutionary artificial...
NOSOPHARM

NOSOPHARM

NOSOPHARM Nosopharm is a biotech startup developing new anti-infectious...
« Older Entries

Recent Posts

  • Theranexus presents an update on the progress of its main programs and announces its cash position as of 31 December 2020. Implemantation of a new equity line.
  • Amolyt Pharma Receives Orphan Drug Designation for AZP-3601 for the Potential Treatment of Hypoparathyroidism
  • Theranexus, Lyon Neuroscience Research Center and CERMEP announce the creation and funding of new joint public/ private laboratory “NeuroImaging for Drug Discovery” (NI2D)
  • Amolyt Pharma announces research collaboration with PeptiDream
  • The Food and Drug Administration (FDA) issues a favorable opinion on the preclinical development plan submitted by Theranexus and BBDF

Recent Comments

    Archives

    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • July 2020
    • April 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • July 2019
    • March 2019
    • February 2019
    • December 2018
    • November 2018
    • December 2017
    • September 2017
    • April 2017

    Categories

    • News portfolio

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About us

    Kreaxi is an investment management firm specialized in the equity financing of innovative, deeptech & lowtech startups with high growth potential. Kreaxi manages regional funds in France, focusing on Auvergne-Rhône-Alpes region as well as French and pan-european funds.

    Lyon

    101, Chemin Vert
    69760 Limonest 
    France

    +33 4 72 52 39 39

    Paris

    13-15 rue Taitbout
    75009 Paris
    France

    +33 1 73 02 89 69

    Register to recieve our Krea-Venture newsletter

    • Twitter
    © 2021 Kreaxi. Tous droits réservés. Mentions légales. Informations réglementaires. Démarche ESG.